Bacterial toxins: An overview on bacterial proteases and their action as virulence factors

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 7, 2009, Pages 820-828

  Lebrun, I ^a   Marques Porto, R ^a   Pereira, A S ^a   Pereira, A ^a   Perpetuo, E A ^b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bacteria; Bordetella pertussis; Clostridium; Proteases; Virulence factors

Indexed keywords

ADENYLATE CYCLASE TOXIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN E; CYTOTOXIN; DIPHTHERIA TOXIN; HEMAGGLUTININ; INTERLEUKIN 1BETA; PERTACTIN; PERTUSSIS TOXIN; PROTEINASE; PEPTIDE HYDROLASE; VIRULENCE FACTOR;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ATROPHIC RHINITIS; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BORDETELLA PERTUSSIS; CLOSTRIDIUM BOTULINUM; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; LISTERIA MONOCYTOGENES; NONHUMAN; PERTUSSIS; PROTEUS MIRABILIS; REVIEW; SPASTIC PARESIS; ANIMAL; BACTERIUM; ENZYMOLOGY; METABOLISM; PATHOGENICITY; VIRULENCE;

ANIMALS; BACTERIA; BACTERIAL TOXINS; HUMANS; PEPTIDE HYDROLASES; VIRULENCE; VIRULENCE FACTORS;

EID: 68849106488     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788452603     Document Type: Review

References (88)

1. Darwin, C.R. The origin of species by means of natural selection, or the preservation of favoured races in the struggle for life., John Murray, 6th ed: London, 1872. Available online in: http://darwinonline.org.uk/content/frameset?itemID=F391&viewtype= text&pageseq=1.
2. Pineda, R.; Alba, J.; Thalasso, F.; Ponce-Noyola, T. Microbial characterization of organic carrier colonization during a model biofiltration experiment. Lett. Appl. Microbiol., 2004, 35(6), 522-26.
3. Klemm, P.; Hancock, V.; Shcembri, M.A. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun., 2007, 75 (8), 3688-3695.
4. Hiltner, P. & Dehority, B.A.:Effect of soluble carbohydrates on digestion of cellulose by pure cultures of rumen bacteria. Appl. Environ. Microbiol., 1983, 46 (3), 642-648.
5. Salminen, S.J.; Gueimonde, M.; Isolauri, E. Probiotics that modify disease risk. J. Nutr., 2005, 135 (5), 1294-1298.
6. Kauffman, C.A. Fungal Infections. Proc. Am. Thorac. Soc., 2006, 3 (1), 35-40.
7. Morgan, A.D.; Brockhurst, M.A.; Lopez-Pascua, C.P.; Buckling, A. Differential impact of simultaneous migration on coevolving hosts and parasites. BMC Evol. Biol., 2007, 7 (1).
8. Brown, N.F.; Wokham, M.E.; Coombas, B.K.; Finlay, B.B. Crossing the line: Selection and evolution of virulence traits. PLoS Pathog., 2006, 2 (5), 346-353.
9. Isenberg, H.D. Pathogenicity and virulence: another view. Clin. Microbiol. Rev., 1998 (1), 40-53.
10. Pfenning, K.S. Evolution of pathogen virulence: the role of variation in host phenotype. Proc. R. Soc. Lond., B, Biol. Sci., 2001, 268 (1468), 755-760.
11. Locht, C. Molecular aspects of Bordetella pertussis pathogenesis. Int. Microbiol., 1999, 2 (3), 137-144.
12. Kaper, J.B.; Nataro, J.P.; Mobley, H.L.T. Pathogenic Escherichia coli. Nat. Rev. Microbiol., 2004, 2 (2), 123-140.
13. Cohen, B. L. Transport and utilization of proteins by fungi. In Microrganisms and nitrogen sources; Payne, J.W. Ed.; J. Wiley and Sons: London, U.K. 1990; p. 411
14. Secades, P.; Guijarro J. A. Purification and characterization of an extracellular protease from fish pathogen Yersinia ruckeri and effect of culture conditions on production. Appl. Environ. Microbiol., 1999, 65 (9), 3969-3975.
15. Tersariol, I.L.S.; Pimenta, D.C; Chagas, J.R.; Almeida, P.C. Proteinase activity regulation by glycosaminoclycans. Braz. J. Med. Biol. Res., 2002, 35 (20), 135-144.
16. IUBMB: International Union of Biochemistry and Molecular Biology. EC 3. Hydrolase Nomenclature - Enzyme nomenclature recommendations. University of London: London, 2007. Available online: http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/.
17. Rao, M.B.; Tatanksale, M.A.; Ghatge, M.S.; Deshpande, V.V. Molecular and biotechnological aspects of microbial proteases. Microbiol. Mol. Biol. Rev., 1998, 62 (3), 597-635.
18. Saeki, K.; Ozaki, K.; Kobayashi, T.; Ito, S. Detergent alkaline proteases: enzymatic properties, genes, and crystal structures. J. Biosci. Bioeng., 2007, 103 (6), 501-508.
19. Hyun, T.H.; Tamura, T. Trienzyme extraction in combination with microbiologic assay in food folate analysis: an updated review. Exp. Biol. Med., 2005, 230 (7), 444-454.
20. Anéas, M.A.; Portaro, F.C.; Lebrun, I.; Juliano, L.; Palma, M.S.; Fernandes BL. ZapA, a possible virulence factor from Proteus mirabilis exhibits broad protease substrate specificity. Braz. J. Med. Biol. Res., 2001, 34 (11), 1397-403.
21. Portnoy, D.A.; Auerbuch, V.; Glomski, I.J. Cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J. Cell Biol., 2002, 158 (3), 409-414.
22. Schiavo, G; Benfenatti, F.; Poulain, B; Rosseto, O.; Polverino De Lauretto, P.; DasGupta, B. R.; Montecucco, C. Tetanus and botulinum B neurotoxins block neurotransmitter release by a proteolytic cleavage of synaptobrevin. Nature, 1992, 359 (6398), 832-835.
23. Montecucco, C.; Papini, E.; Schiavo, G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett., 1994, 346 (1), 92-98.
24. Barret, A.J.; Rawlings, N.D.; Woessner, J.F. Handbook of Proteolytic Enzymes (EDS), Academic Press: London, 1998, p569.
25. Niemann, H.; Binz, T.; Grebenstein, O.; Kurazono, H.; Thierer, J.; Mochida, S.; Poulain, B.; Tauc, L. Clostridial neurotoxins: from toxins to therapeutic tools, Behring Inst. Mitt. 1991 (89), 153-62.
26. Shone, C.C.; Ouinn, C.P.; Wait, R.; Hallis, B.; Fooks, S.G.; Hambleton, P. Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. Eur. J. Biochem., 1993, 217 (3), 965-971.
27. Dolly, J.O.; Ashton, A.C.; McInnes, C.; Wadsworth, J.D.; Poulain, B.; Tauc, L.; Shone, C.C.; Melling, J. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters. J. Physiol. (Paris), 1990, 84 (3), 237-46.
28. Schiavo, G.; Rosseto, O.; Catsicas, S.; Polverino De Lauretto, P.; DasGupta, B.R.; Benfenatti, F.; Montecucco, C. Identification of the nerve-terminal targets of botulinum neurotoxins serotype A, D and F. J. Biol. Chem., 1993a, 268 (32), 23784-23787.
29. Schiavo, G.; Santucci, A.; Dasgupta, B.R.; Mehta, P.P.; Jontes, J.; Benfenati, F., Wilson, M.C.; Montecucco, C. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett., 1993b, 335 (1), 99-103.
30. Schiavo, G.; Rossetto, O; Santucci, A.; DasGupta, B.R.; Montecucco, C.: Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 1992, 267 (33), 23479-83.
31. Blasi, J.; Chapman, E. R.; Link, E.; Binz, T.; Yamasaki, S.; Decamilli, P.; Südhof, T.; Niemann, H.; Jahn, R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature, 1993a, 365 (6442), 160-163.
32. Blasi, J.; Chapman, E. R.; Yamasaki, S.; Binz, T.; Niemann, H.; Jahn, R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-I/sintaxina. EMBO J. 1993b (12), 4821-4828.
33. Supuran, C.T. Bacterial proteases: Current therapeutic use and future prospects for development of new antibiotics. Exp. Opin. Ther. Pat., 2001, 11 (2), 221-259.
34. Montecucco, C..In: Handbook of Proteolytic Enzymes, Barret, A.J. Rawlings, N.D., Woessner, JF Academic Press: London, 1998; p509.
35. Carrol, S.F.; Collier, J. Diphtheria toxin: Quantification and Assay. Methods Enzymol., 1988, 165, 218-25..
36. Mattoo, S.; Foreman-Wykert, A.K.; Cotter, P.A.; Miller, J.F. Mechanisms of Bordetella pathogenesis. Front Biosci., 2001, 1(6), E168-86.
37. Walker, K.E.; Weiss, A.A., Characterization of the Dermonecrotic Toxin in Members of the Genus Bordetella. Infect. Immun., 1994, 62 (9)3817-3828.
38. Carbonetti, N. H. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr. Opin. Pharmacol., 2007, 7 (3), 272-278.
39. Gould-Kostka J.L.; Burns, D.L.; Brennan, M.J.; Manclark, C.R. Purification and analysis of the antigenicity of a 69000 Da protein from B. pertussis. FEMS Microbiol. Lett., 1990, 55 (3), 285-9.
40. Munoz, J.J. Biological activities of pertussigen (pertussis toxin). In: Pertussis toxin. Sekura, R.D.; Moss, J.; Vaughan, M. Eds. Academic Press Inc: London: 1985, 1-18.
41. Miller, D., Madge, N., Diamond, J.; Wadsworth, J.; Ross, E. Pertussis immunization and serious acute neurological illnesses in children. Br. Med. J., 1993, 307 (6913), 1171-6.
42. Donnelly, S.; Loscher, C.E.; Lynch, M.A.; Mills, K.H.G. Wholecell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1 in a new murine model for analysis of neuronal side effects of vaccination. Infec. Immun., 2001, 69 (7), 4217-23.
43. Tamura, M.; Nogimori, K.; Murai, S.; Yajima, M.; Ito, K.; Katada, T. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochem., 1982, 21 (22), 5516-22.
44. Sekura, R.D.; Fish, F.; Manclark, C.R.; Meade, B.; Zhang, Y.L. Pertussis toxin. Affinity purification of a new AD-Pribosyltransferase. J. Biol. Chem., 1983, 258 (23), 14647-51.
45. Ui, M. Pertussis toxin as a valuable probe for G-protein: involvement in signal transduction. In: ADP-ribosylaing toxins and G protein. Moss, J.; Vaughan, M. Eds. American Society for Microbiology, Washington, DC: 1990, 45-77.
46. Katada, T.; Ui, M. Islet-activating protein. A modifier of receptor mediated regulation of rat islet adenylate cyclase. J. Biol. Chem., 1981, 256 (16), 8310-7.
47. Tamura, M.; Nogimori, K.; Yajima, M.; Ase, K.; Ui, M. A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells. J. Biol. Chem., 1983, 258 (11), 6756-61.
48. Pizza, M.; Covacci, A.; Bartoloni, A.; Perugini, M.; Nencioni, L.; De Magistris, M.T. Mutants of pertussis toxin suitable for vaccine development. Science, 1989, 246 (4929), 497-500.
49. Rappuoli, R. Rational design of vaccines. Nat. Med., 1997, 3 (4), 374-6.
50. Goldman, W. E.; Klapper, D. G.; Baseman, J. B. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect. Immun., 1982, 36 (2), 782-794
51. Olson, L. C. Pertussis, Medicine, 1975, 54 (6), 427-469.
52. Cookson, B.T.; Tyler, A.N.; Goldman, W.E. Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry, 1989, 28 (4), 1744-49.
53. Chedid L. Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol. Immunol., 1983, 27 (9), 723-32.
54. Kotani, S.; Tsujimoto, M.; Koga, T.; Nagao, S.; Tanaka, A.; Kawata, S. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed. Proc., 1986, 45 (11), 2534-40
55. Gentry-Weeks, C.R.; Cookson, B.T.; Goldman, W.E.; Rimler, R.B.; Porter, S.; Curtiss, R. III Dermonecrotic toxin and tracheal cytotoxin: putative virulence factors of Bordetella avium. Infect. Immun., 1988, 56, 1698-1707.
56. Cookson, B.T.; Goldman, W.E. Tracheal cytotoxin: a conserved virulence determinant of all Bordetella species. J. Cell. Biochem., 1987, 11 (Suppl. B), 124 (abstr.).
57. Bordet, J.; Gengou, O. L'endotoxine coquelucheuse. Ann. Inst. Pasteur (Paris)., 1999, 23, 415-19.
58. Parton, R. Effect of prednisolone on the toxicity of Bordetella pertussis for mice. J. Med. Microbiol., 1985, 19 (3), 391-400.
59. Pereira, A., Pereira, A.S.P.; Moreira-Filho, C.A.; Bando, S.Y.; Tambourgi, D.V. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine. Vaccine, 2005, 23 (34), 4353-8.
60. Cowell, J. L.; Hewlett, E.; Manclark, C.R. Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect. Immun., 1979, 25 (3), 896-901
61. Nakai, T.; Sawata, A.; Kume, K. Intracellular locations of dermonecrotic toxins in Pasteurella multocida and Bordetella bronchiseptica. Am. J. Vet. Res., 1985, 46 (4), 870-874.
62. Horiguchi, Y.; Nakai, Y.; Kume K. Simplified procedure for of Bordetella bronchiseptica dermonecrotic toxin. FEMS Microbiol. Lett., 1990, 54 (1-3), 39-43.
63. Zhang, Y. L.; Sekura, R.D. Purification and characterization of the heat-labile toxin of Bordetella pertussis. Infect. Immun., 1991, 59 (10), 3754-3759.
64. Weiss, A. A.; Goodwin, M.S.M. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun., 1989, 57 (12), 3757-3764.
65. Rutter, J. M.; Mackenzie, A. Pathogenesis of atrophic rhinitis in pigs: a new perspective. Vet. Rec., 1984, 114 (4), 89-90.
66. Goodnow, R. Biology of Bordetella bronchiseptica. Microbiol. Rev., 1980, 44 (4), 722-738.
67. Chen, W.; Alley, M.R.; Manktelow, B.W. Experimental induction of pneumonia in mice with Bordetella parapertussis isolated from sheep. J. Comp. Pathol., 1989, 100 (1), 77-88.
68. Rimler, R.D. Turkey coryza: toxin production by Bordetella avium. Avian Dis., 1985, 29 (4), 1043-1047.
69. Weiss, A.A.; Melton, A.R.; Walker, K.E.; Andraos-Selim, C.; Meidl, J.J. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect. Immun., 1989, 57 (9), 2674-2682.
70. Petersen, S. K.; Foged, N.T. Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli. Infect. Immun., 1989, 57 (12), 3907-3913.
71. Rozengurt, E.; Higgins, T.; Chanter, N.; Lax, A.JStaddon, J.M. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. USA, 1990, 87 (1), 123-137.
72. Ladant, D.; Ullmann, A. Bordatella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol., 1999, 7 (4), 172-176.
73. Rogel, A.; Hanski, E. Distinct steps in the penetration of adenylate cyclase toxin of Bordetella pertussis into sheep erythrocytes. Translocation of the toxin across the membrane. J. Biol. Chem., 1992, 267 (31), 22599-22605
74. Guermonprez, P.; Khelef, N.; Blouin, E.; Rieu, P. Ricciardi-Castagnoli, P.; Guiso, N.; Ladant, D.; Leclerc, C. The adenylate cyclase toxin of Bordetella pertussis binds to 8 target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J. Exp. Med., 2001, 193 (9), 1035-1044.
75. Mills, K. H. Immunity to Bordetella pertussis. Microbes Infect., 2001, 3 (8), 655-677.
76. Boyd, A. P.; Ross, P.J.; Conroy, H.; Mahon, N.; Lavelle, E.C.; Mills, K.H. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J. Immunol., 2005, 175 (2), 730-738.
77. Fiser, R.; Masin, J.; Basler, M.; Krusek, J.; Spulakova, V.; Konopasek, I.; Sebo, P. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities. J. Biol. Chem., 2007, 282 (5), 2808-2820.
78. Goodwin, M. S.; Weiss, A.A. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect. Immun., 1990, 58 (10), 3445-3447.
79. Vojtova, J.; Kamanova, J.; Sebo, P. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr. Opin. Microbiol., 2006, 9 (1), 69-75.
80. Bagley, K. C.; Abdelwahab, S.F.; Tuskan, R.G.; Fouts, T.R.; Lewis, G.K. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J. Leukoc. Biol., 2002, 72 (5), 962-9.
81. Torgersen, K. M.; Vang, T.; Abrahamsen, H.; Yaqub, S.; Tasken, K. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal., 2002, 14 (1), 1-9.
82. Bos, J. L. Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell. Biol., 2003, 4 (9), 733-738.
83. Delgado, M.; Ganea, D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages. J. Neuroimmunol., 2000, 110 (1-2), 97-105.
84. Aronoff, D. M.; Carstens, J.K.; Chen, G.H.; Toews, G.B.; Peters-Golden, M. Short communication: differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis. J. Interferon Cytokine Res., 2006, 26 (11), 827-833.
85. Bryn, T.; Mahic, M.; Enserink, J.M.; Schwede, F.; Aandahl, E.M.; Tasken, K. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J. Immunol., 2006, 176 (12), 7361-7370.
86. Lorenowicz, M. J.; Fernandez-Borja, M.; Hordijk, P.L. cAMP signaling in leukocyte transendothelial migration. Arterioscler. Thromb. Vasc. Biol., 2007, 27 (5), 1014-1022.
87. Fimia, G. M.; Sassone-Corsi, P. Cyclic AMP signalling. J. Cell. Sci., 2001, 114 (pt11), 1971-2.
88. Paccani, S.R.; Dal Molin, F.; Benagiano, M.; Ladant, D.; D'Elios, M.M.; Montecucco, C., Baldari, C.T.; Suppression of Tlymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect. Immun., 2008, 76 (7), 2822-32.